Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02868606 · ClinicalTrials.gov registry record
Physiologic Insulin Therapy for the Management of Hyperglycemia in the Hospital
A clinical trial, sponsored by Winthrop University Hospital.
- Completed
- Registry status
- 40,391
- Enrollment target
NCT02868606 is a clinical trial that has completed, run by Winthrop University Hospital. The registered enrollment target is 40,391 participants.
The verdict
NCT02868606 has completed, sponsored by Winthrop University Hospital.
- COMPLETED
- Registry status
- 40,391 participants
- Enrollment target
Study Summary
Many hospitals have begun giving insulin to nearly all patients with diabetes while they are in the hospital even if a patient does not use insulin at home. Controlling blood sugar with insulin when a patient is hospitalized is believed to reduce the risk of complications and death, but research has not demonstrated these benefits except in patients who are critically ill. The purpose of this study, therefore, is to evaluate whether such insulin therapy actually does reduce in-hospital complications, deaths, need for intensive care, or length of stay in the hospital.
Interventions
- OTHER Physiologic Insulin Therapy
- OTHER Sliding-Scale Insulin Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40,391 participants |
| Start Date | 2015-07 |
| Est. Completion | 2018-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02868606
The ClinicalTrials.gov registry entry for NCT02868606 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40,391 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Winthrop University Hospital, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Physiologic Insulin Therapy is the first listed.
NCT02868606 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02868606 about?
NCT02868606 is a clinical study titled "Physiologic Insulin Therapy for the Management of Hyperglycemia in the Hospital". Many hospitals have begun giving insulin to nearly all patients with diabetes while they are in the hospital even if a patient does not use insulin at home. Controlling blood sugar with insulin when a patient is hospitalized is believed to reduce the risk of complications and death, but research has...
What is the current status of trial NCT02868606?
This trial is currently completed. The enrollment target is 40,391 participants. The study started on 2015-07. Estimated completion is 2018-06-30.
What interventions are being tested in trial NCT02868606?
The interventions under investigation include: Physiologic Insulin Therapy (OTHER), Sliding-Scale Insulin Therapy (OTHER).
Who is sponsoring clinical trial NCT02868606?
This trial is sponsored by Winthrop University Hospital, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.